Aligos Therapeutics Inc., a startup headed by entrepreneurs who led venture-backed Alios BioPharma Inc. to a $1.75 billion merger with Johnson & Johnson in 2014, has raised $125 million to develop treatments for hepatitis B and other liver diseases.
Startup Aligos Grabs $125 Million for Drugs to Combat Hepatitis B Read More »
NEW YORK, Nov. 06, 2019 (GLOBE NEWSWIRE) — LifeSci Public Relations LLC (LifeSci PR) today announced that Vicki O’Neil has been named creative director.
LifeSci Public Relations Appoints Vicki O’Neil as Creative Director Read More »
NEW YORK, Nov. 26, 2018 – LifeSci Public Relations LLC (LSPR) today announced the launch of its Social and Digital Media Division with the hiring of Jessica Snider as its director
LifeSci Public Relations Launches Social and Digital Media Division Read More »
Amit Munshi President/CEO Arena Pharmaceuticals Inc Discussing drug development in ulcerative colitis space.
Bloomberg Markets: ICO Compliance, Drug Development Read More »
Looking at the performance of Arena Pharmaceuticals with CEO Amit Munshi and CNBC’s Meg Tirrell.
Arena CEO: We have two great assets and are trying to build a company around that Read More »
As an engineering professor at Lehigh University in Pennsylvania, Richard P. Vinci has run plenty of experiments. He specializes in figuring out what makes materials break…
Trials for potential ALS treatment spark cautious hope Read More »
Forty-one-year-old David Neufeglise was a healthy family man and mechanical engineer when he started noticing constant twitching in his arm…
ALS patient hopes stem cell treatment will be “a powerful weapon” Read More »
